Einstein-Montefiore Clinical and Translational Science Award Hub

爱因斯坦-蒙蒂菲奥里临床和转化科学奖中心

• 批准号: 10622099
• 负责人: MARLA J KELLER
• 金额: $ 436.8万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-03 至 2030-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10622099
• 关键词: Abbreviations; Acceleration; Acute; Biomedical Research; COVID-19 pandemic; COVID-19 vaccination; Cessation of life; Clinic; Clinical; Clinical Engineering; Clinical Informatics; Clinical Research; Clinical Sciences; Clinical and Translational Science Awards; Communication; Communities; County; Data Science; Discipline of Nursing; Dissemination and Implementation; Effectiveness; Electronic Health Record; Ensure; Environment; Ethnic Origin; Evaluation; Evidence based program; Exclusion; Funding; Goals; Health; Health Benefit; Health Professional; Health system; Healthcare; Hispanic-serving Institution; Home; Informatics; Infrastructure; Institution; Laboratories; Lead; Leadership; Learning; Life Cycle Stages; Medical center; Medicine; Mentors; Methodology; Operations Research; Participant; Pathway interactions; Patients; Population Research; Prevention strategy; Process; Protocols documentation; Public Health; Race; Reduce health disparities; Research; Research Design; Research Personnel; Resource Informatics; Resources; Safety; Science; Services; Target Populations; Technology; Therapeutic; Training; Training Programs; Translation Process; Translational Research; Translations; Vision; Woman; clinical trial recruitment; college; community engagement; community partnership; coronavirus disease; data sharing; disorder prevention; ethnic minority; health care quality; health disparity; health equity; health equity promotion; health inequalities; implementation strategy; improved; inequitable distribution; innovation; large datasets; member; multidisciplinary; novel; open data; patient population; population health; premature; process improvement; programs; racial minority; skills; social health determinants; socioeconomics; study population; translational pipeline; treatment strategy; uptake; vaccine acceptance

The Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at the Albert Einstein College of Medicine and Montefiore Medical Center serves as the home of our CTSA program. The vision of the ICTR is to improve the health of the Bronx, and other communities that disproportionately and unjustly suffer from poor heath and premature death, by accelerating the translation of biomedical discoveries into effective and sustainable disease prevention and treatment strategies. Created in 2007, the ICTR has transformed clinical and translational research (CTR) throughout Einstein and Montefiore by creating a robust research environment; re- engineering CTR processes; integrating research and healthcare; and developing strong community relationships. The ICTR theme of “Building Bridges in the Bronx and Beyond” underscores the importance of bridging gaps between our researchers, health system leaders, clinicians, patients, communities, and CTSA partners to advance translational science and health equity. The specific aims of the ICTR are to: (1) Catalyze innovations that will enhance the efficiency and effectiveness of translational research. We will support and fund studies with high potential to overcome major CTR roadblocks and health inequities; create methodological and informatics translational science innovations; improve CTR operations, and enhance dissemination and implementation strategies. (2) Engage communities, patients, and other partners early and throughout the translational process. Our new Community and Stakeholder Engagement Research module will transform our learning health system into a “learning health research community”; promote active and continuous bidirectional communication with communities, patients and other partners; facilitate research to identify and mitigate social determinants of health, and enhance uptake of evidence-based programs by target populations. (3) Develop and implement state-of-the-art clinical research and informatics resources and services to improve the rigor, safety, efficiency, effectiveness, and generalizability of CTR. (4) Train, develop, and maintain a skilled, multidisciplinary, and diverse translational workforce to support and lead high quality research with new training and pathway programs to ensure members of historically excluded groups engage in CTR and become research leaders. (5) Partner with other CTSA hubs and the CTSA consortium to accelerate CTR and rapidly respond to urgent public health needs. Our aims are aligned with the new CTSA program goals and will enable the ICTR to maximally contribute to the collective efforts of the national collaborative CTSA consortium to deliver more treatments to more patients more quickly in the Bronx and beyond.

哈罗德和穆里尔布洛克临床和转化研究所（ICTR）在阿尔伯特爱因斯坦